SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001933414-23-000081
Filing Date
2023-11-02
Accepted
2023-11-02 10:06:10
Documents
14
Period of Report
2023-11-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mlys-20231102.htm   iXBRL 8-K 28520
2 EX-99.1 mlys202311028kex991.htm EX-99.1 19317
6 min_logoxprimaryxfullcolor.jpg GRAPHIC 594484
  Complete submission text file 0001933414-23-000081.txt   790095

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20231102.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20231102_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20231102_pre.xml EX-101.PRE 13589
8 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20231102_htm.xml XML 2929
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41614 | Film No.: 231370502
SIC: 2834 Pharmaceutical Preparations